News
GRRMF
21.57
+7.69%
1.54
Gerresheimer downgraded to Sell from Neutral at UBS
TipRanks · 02/23 19:10
ClearBridge International Value Strategy adds RHHBY and MKGAF; exits GRRMF, AKESF, and HKMPF
Seeking Alpha · 02/19 17:35
Diamond Hill International Strategy Q4 2025 Portfolio Review
Seeking Alpha · 02/17 07:14
Oakmark International Small Cap Strategy Q4 2025 Portfolio Drivers & Decisions
Seeking Alpha · 02/17 00:35
Deutsche Bank Keeps Their Hold Rating on Gerresheimer (0NTI)
TipRanks · 02/16 12:36
Berenberg Bank Remains a Hold on Gerresheimer (0NTI)
TipRanks · 02/16 07:05
DZ BANK AG Reaffirms Their Sell Rating on Gerresheimer (0NTI)
TipRanks · 02/13 04:55
Bernstein Remains a Sell on Gerresheimer (0NTI)
TipRanks · 02/12 14:56
Deutsche Bank Sticks to Their Hold Rating for Gerresheimer (0NTI)
TipRanks · 02/12 11:36
UBS Reaffirms Their Hold Rating on Gerresheimer (0NTI)
TipRanks · 02/11 14:25
Gerresheimer (0NTI) Gets a Buy from J.P. Morgan
TipRanks · 02/11 11:26
Gerresheimer (0NTI) Receives a Hold from Berenberg Bank
TipRanks · 01/23 11:56
Oakmark International Small Cap Fund: buys VISIF, exits GRRMF, JDEPF
Seeking Alpha · 01/20 10:39
Jefferies Sticks to Its Buy Rating for Gerresheimer (0NTI)
TipRanks · 01/17 03:26
Gerresheimer (0NTI) Gets a Buy from Kepler Capital
TipRanks · 01/14 01:51
Gerresheimer (0NTI) Gets a Sell from Bernstein
TipRanks · 01/13 09:57
Jefferies Reaffirms Their Buy Rating on Gerresheimer (0NTI)
TipRanks · 12/23/2025 09:55
DZ BANK AG Sticks to Their Sell Rating for Gerresheimer (0NTI)
TipRanks · 12/23/2025 03:25
Bernstein Sticks to Their Sell Rating for Gerresheimer (0NTI)
TipRanks · 12/16/2025 20:35
Exane BNP Paribas downgrades Gerresheimer (0NTI) to a Sell
TipRanks · 12/12/2025 20:35
More
Webull provides a variety of real-time GRRMF stock news. You can receive the latest news about Gerresheime through multiple platforms. This information may help you make smarter investment decisions.
About GRRMF
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.